How to manage Pediatric Septic Shock?

Published On: 11 Apr, 2024 1:58 PM | Updated On: 11 Apr, 2024 2:17 PM

How to manage Pediatric Septic Shock?

The three pathophysiologic contributors to septic shock are-

Different combinations of hypovolemia (relative > absolute)

Reduced vascular tone or vasoplegia 

Myocardial dysfunction

The three pillars of hemodynamic support are- 

Fluid boluses

Vasopressors with inotrope infusions

Vasopressors without inotrope infusions

The three end-points of hemodynamic resuscitation are-

Adequate cardiac output (CO)

Adequate mean arterial pressure (MAP) and diastolic blood pressure (DBP) for organ perfusion 

Avoiding congestion (worse filling) parameters 


Post-fluid bolus CO improvements are seen only in 33-50% of septic patients, which is sustained in ≥ 10% due to sepsis-mediated glycocalyx injury. A pragmatic approach would be administering a small bolus (10 mL/kg over 20-30 min) and judging the response based on clinical perfusion markers, pressure elements, and congestive features. 

Vasoplegia characterized by low DBP leads to hypotension in septic shock. Hence, restricted fluid bolus with early low-dose norepinephrine (NE) (0.05- 0.1 µg/kg/min) can be useful. NE can also be used as an initial agent in septic myocardial dysfunction (SMD) to hold adequate coronary perfusion and DBP while minimizing tachycardia and providing inotropy. Additional inotropy (epinephrine/dobutamine) benefits severe SMD. Most vasoactive drugs (except vasopressin) may safely be administered via a peripheral route. The lowest MAP (5th centile for age) is an acceptable target, provided end-organ perfusion is satisfactory. 

A clinical individualized approach considering the history, serial physical assessment, laboratory investigations, available monitoring tools, and repeated assessment to individualize circulatory support will help better outcomes than one-size-fits-all algorithms.

Ranjit S, Natraj R. Hemodynamic Management Strategies in Pediatric Septic Shock: Ten Concepts for the Bedside Practitioner. Indian Pediatrics. 2024;61

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks